SCHEMBL20955412

SCHEMBL20955412

CC(C)(C)OC(=O)N1CC2(CCN(C(=O)OCc3ccccc3)CC2)c2ccc(Cl)cc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 2/20 0.64
BIRC2 Q13490 2/20 0.64
HDAC1 Q13547 3/20 0.49
HDAC8 Q9BY41 3/20 0.49
HDAC6 Q9UBN7 3/20 0.49
P2RY1 P47900 1/20 0.44
NPC1L1 Q9UHC9 1/20 0.41
TACR1 P25103 5/20 0.41
SCN5A Q14524 1/20 0.41
SCN9A Q15858 1/20 0.41
CASP1 P29466 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
HTT P42858 1/20 0.40
ENPP2 Q13822 1/20 0.40
ATXN2 Q99700 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20954995 0.89 XIAP (0.52) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL2800892 0.89 HDAC1 (0.56) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL20954809 0.87 HDAC1 (0.51) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL30701483 0.85 XIAP (0.72) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL8221795 0.85 HDAC1 (0.56) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL21989231 0.85 XIAP (0.48) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL15676881 0.84 HDAC1 (0.47) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL20955233 0.84 SCN5A (0.52) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL20955202 0.84 XIAP (0.46) XIAPBIRC2HDAC1HDAC8HDAC6
SCHEMBL20955118 0.83 HDAC1 (0.47) XIAPBIRC2HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3480198-B1 NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF RIKEN (JP) 2021-05-05 EP disclosed
EP-3480198-A1 NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF RIKEN (JP) 2019-05-08 EP disclosed